Edgewise Therapeutics, Inc. (EWTX) vs Option Care Health, Inc. (OPCH)
A side-by-side comparison of Edgewise Therapeutics, Inc. and Option Care Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EWTX
Edgewise Therapeutics, Inc.
$39.94HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
OPCH
Option Care Health, Inc.
$31.04HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — EWTX vs OPCH
growth of $100 · dividends reinvested · last 6yEWTX +34.3% (+5.0%/yr)OPCH +24.0% (+3.7%/yr)EWTX compounded faster over this window
EWTX OPCH
EWTX vs OPCH: by the numbers
- •OPCH is the larger company ($4.65B vs $4.30B market cap).
- •OPCH is profitable (3.68% net margin) while EWTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | EWTX | OPCH |
|---|---|---|
| P/E ratio | N/A | 23.33 |
| Forward P/E | N/A | 16.51 |
| P/S ratio | N/A | 0.82 |
| P/B ratio | 9.59 | 3.69 |
| EV / EBITDA | N/A | 13.97 |
Profitability
| Metric | EWTX | OPCH |
|---|---|---|
| Gross margin | 0.00% | 18.17% |
| Operating margin | 0.00% | 5.94% |
| Net margin | 0.00% | 3.68% |
| ROE | -44.02% | 16.63% |
| ROIC | -48.57% | 9.68% |
Growth (annualized)
| Metric | EWTX | OPCH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.17% |
| Total return CAGR (5Y) | 16.95% | -1.37% |
Frequently asked
- Is EWTX or OPCH more profitable?
- OPCH runs the higher net margin — EWTX at 0.00% versus OPCH at 3.68%.
- How have EWTX and OPCH total returns compared?
- Over the past 5 years, EWTX delivered 16.95% and OPCH delivered -1.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.